UBS Group »

Inmed Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $399 377 1.06
2025-06-30 $25k 7.8k 3.25
2025-03-31 $13k 6.1k 2.07
2024-12-31 $49k 10k 4.74